Fiber in the treatment and maintenance of inflammatory bowel disease: A systematic review of randomized controlled trials

Inflammatory Bowel Diseases

Volumn 20, Issue 3, 2014, Pages 576-586

  Wedlake, Linda ^a,b   Slack, Natalie ^b   Andreyev, H Jervoise N ^a   Whelan, Kevin ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Crohn's disease; Fiber; Gastrointestinal; Inflammatory bowel disease; Pouchitis; Prebiotic; Ulcerative colitis

Indexed keywords

BUTYRIC ACID; CALGRANULIN; CYTOKINE;

CROHN DISEASE; DATA BASE; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE ACTIVITY; GASTROINTESTINAL SYMPTOM; HUMAN; ILEITIS; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; ULCERATIVE COLITIS;

DIETARY FIBER; HUMANS; INFLAMMATORY BOWEL DISEASES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84898726597     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000437984.92565.31     Document Type: Review

References (46)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology. 2004; 126:1504-1517.
2. Bernklev T, Jahnsen J, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis. 2005;11:909-918.
3. Gerasimidis K, McGrogan P, Edwards CA. The aetiology and impact of malnutrition in paediatric inflammatory bowel disease. J Hum Nutr Diet. 2011;24:313-326.
4. Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology. 2011;140:1729-1737.
5. Talley NJ, Abreu MT, Achkar JP, et al. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011;106:S2-S25.
6. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2007;CD000542.
7. Davies PS, Rhodes J. Maintenance of remission in ulcerative colitis with sulphasalazine or a high-fibre diet: a clinical trial. Br Med J. 1978;1: 1524-1525.
8. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:718-727.
9. Gassull MA. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(suppl 3): 90-95.
10. Woolner JT, Parker TJ, Kirby GA, et al. The development and evaluation of a diet for maintaining remission in Crohn's disease. J Hum Nutr Diet. 1998;11:1-11.
11. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn's disease with an unrefined-carbohydrate, fibre-rich diet. Br Med J. 1979;2:764-766.
12. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (Updated September 2008). Chichester, United Kingdom: Cochrane Collaboration; 2008.
13. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-W94.
14. Moher D, Tricco AC. Issues related to the conduct of systematic reviews: a focus on the nutrition field. Am J Clin Nutr. 2008;88:1191-1199.
15. Department of Health. Report on Health and Social Subjects No. 41. Chapter 4 Non-starch Polysaccharides in Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London, United Kingdom: HMSO; 1991.
16. Cummings JH, Mann JI, Nishida C, et al. Dietary fibre: an agreed definition. Lancet. 2009;373:365-366.
17. Mann JI, Cummings JH. Possible implications for health of the different definitions of dietary fibre. Nutr Metab Cardiovasc Dis. 2009;19:226-229.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
19. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol. 1999;94:427-433.
20. Hallert C, Kaldma M, Petersson BG. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scand J Gastroenterol. 1991;26:747-750.
21. Copaci I, Chira C, Rovinaru I, et al. Maintenance of remission of ulcerative colitis (UC): mesalamine, dietary fiber, S. boulardi. Dig Liver Dis. 2000;32(suppl 1):A2.
22. Faghfoori Z, Navai L, Shakerhosseini R, et al. Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-a, interleukin-6 and-8 in patients with ulcerative colitis. Ann Clin Biochem. 2011;48:233-237.
23. Federico A, Tuccillo C, Grossi E, et al. The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study. Eur Rev Med Pharmacol Sci. 2009;13:285-293.
24. Furrie E, Macfarlane S, Kennedy A, et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54:242-249.
25. Casellas F, Borruel N, Torrejon A, et al. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered fecal calprotectin. Aliment Pharmacol Ther. 2007;25:1061-1067.
26. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol. 2002;37(suppl 14):67-72.
27. Ishikawa H, Matsumoto S, Ohashi Y, et al. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomised controlled study. Digestion. 2011;84:128-133.
28. Fujimori S, Gudis K, Mitsui K, et al. A randomised controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition. 2009;25:520-525.
29. Chermesh I, Tamir A, Reshef R, et al. Failure of Synbiotic 2000 to prevent postoperative recurrence of Crohn's disease. Dig Dis Sci. 2007;52:385-389.
30. Rutgeerts P, D'Haens G, Baert F, et al. Randomized placebo controlled trial of pro-and prebiotics (synbiotics cocktail) for maintenance of infliximab induced remission of luminal Crohn's disease (CD). Gastroenterology. 2004;126:A467.
31. Jones VA, Dickinson RJ, Workman A, et al. Crohn's disease: maintenance of remission by diet. Lancet. 1985;2:177-180.
32. Ritchie JK, Wadsworth J, Lennard-Jones JE, et al. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J (Clin Res Ed). 1987;295:517-520.
33. Steed H, Macfarlane GT, Blackett KL, et al. Clinical trial: the microbiological and immunological effects of synbiotic consumption-a randomized double-blind placebo-controlled study in active Crohn's disease. Aliment Pharmacol Ther. 2010;32:872-883.
34. Benjamin JL, Hedin CRH, Koutsoumpas A, et al. Randomised, doubleblind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut. 2011;60:923-929.
35. Koch H. Adjuvant treatment of Crohn's disease with a Psyllium preparation [in German]. Therapiewoche. 1984;34:4545-4548.
36. Bartel G, Weiss I, Turetschek K, et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflamm Bowel Dis. 2008;14:374-382.
37. Brotherton CS, Taylor AG, Anderson JG. Can a high fiber diet improve bowel function and health-related quality of life in patients with Crohn's disease? FASEB J. 2012;26:1b338.
38. Joossens M, De Preter V, Ballet V, et al. Effect of oligofructose- enriched inulin (OF-IN) on bacterial composition and disease activity of patinets with Crohn's disease: results from a double-blinded randomised controlled trial. Gut. 2012;61:958.
39. Levenstein S, Pranter C, Luzi C, et al. Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut. 1985;26:989-993.
40. Stange EF, Schmid U, Fleig WE, et al. Exclusion diet in Crohn's disease: a controlled, randomised study [in German]. Z Gastroenterol. 1990;28:561-564.
41. Welters CFM, Heineman E, Thunnissen FBJM, et al. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum. 2002;45:621-627.
42. Sears CL. Enterotoxigenic Bacteriodes fragilis: a rogue among symbiotics. Clin Microbiol Rev. 2009;22:349-369.
43. Freeman HJ. Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients. Can J Gastroenterol. 2007;21:363-366.
44. Hallert C, Bjorck I, Nyman M, et al. Increasing faecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm Bowel Dis. 2003;9:116-121.
45. Hanai H, Kanauchi O, Mitsuyama K, et al. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med. 2004; 13:643-647.
46. Van Loo J, Bosscher D, Franck A, et al. On the use of prebiotic food ingredient Synergy1 (Oligofructose enriched inulin) in the management of inflammatory bowel disease. FASEB J. 2006;20: A989.